Fatty liver disease, medically termed hepatic steatosis, affects many UK veterans who may be entitled to compensation if their condition is linked to military service. Whether caused by service-related medications, injuries limiting mobility, or other documented factors during deployment, veterans can claim support through the Armed Forces Compensation Scheme (AFCS) or War Pension Scheme. Understanding eligibility criteria, required medical evidence, and the application process is essential for securing financial support. This guide explains how UK veterans can navigate compensation claims for service-related fatty liver disease, including diagnostic requirements, tariff levels, and practical steps to strengthen your application.

Understanding Fatty Liver Disease and UK Veterans' Compensation

Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates in liver cells. This condition exists in two primary forms: non-alcoholic fatty liver disease (NAFLD), which develops independently of alcohol consumption, and alcoholic fatty liver disease (AFLD), directly linked to excessive alcohol intake. Both variants can progress from simple steatosis to more serious conditions including steatohepatitis, fibrosis, and ultimately cirrhosis if left unmanaged. (Note: NAFLD is increasingly referred to as metabolic dysfunction-associated steatotic liver disease (MASLD) in some guidance, though NAFLD remains the term used in current UK clinical pathways.)

For military veterans, fatty liver disease may develop or worsen due to service-related factors. Service-connected injuries leading to reduced mobility, psychological conditions resulting in weight gain, or certain medications administered during service can contribute to hepatic steatosis. The condition often remains asymptomatic in early stages, and liver function tests (LFTs) may be normal even when significant steatosis is present. Some individuals experience fatigue, right upper quadrant discomfort, or general malaise.

UK veterans seeking support for service-related fatty liver disease should understand the provisions available through the Armed Forces Compensation Scheme (AFCS) and War Pension Scheme. These UK-specific programmes provide financial compensation and healthcare support for conditions caused by or attributable to military service. Understanding the medical nature of fatty liver disease and establishing a clear service connection forms the foundation of any successful claim.

The pathophysiology involves hepatocyte accumulation of triglycerides, often associated with metabolic syndrome components including obesity, type 2 diabetes, dyslipidaemia, and hypertension. According to NICE guideline NG49, assessment focuses on identifying advanced fibrosis, as this determines prognosis and need for specialist referral. Recognition of fatty liver disease as a potentially service-connected condition has increased as understanding of occupational risk factors has evolved within military medicine.

Eligibility Criteria for UK Veterans' Compensation

For UK veterans, eligibility for compensation related to fatty liver disease depends on demonstrating a clear link between military service and the condition's development or significant worsening. Under the Armed Forces Compensation Scheme (AFCS), which applies to injuries or illnesses caused by service on or after 6 April 2005, claimants must prove their condition resulted from service on the balance of probabilities. The earlier War Pension Scheme covers those who served before this date and also operates on a balance of probabilities standard, assessing whether the condition is attributable to or aggravated by service.

Key eligibility factors include:

• Causation: Evidence that military service caused or materially contributed to the liver condition through service-related medications, circumstances leading to metabolic dysfunction, or other documented service factors

• Timing: Documentation showing the condition developed during service or within a reasonable timeframe afterwards. AFCS claims must generally be made within 7 years of the date of injury, diagnosis, or when the claimant first knew the condition was caused by service. The War Pension Scheme has no time limit, though earlier claims are recommended

• Medical evidence: Clinical diagnosis and medical opinion supporting the link between specific service experiences and hepatic steatosis

• Severity: The degree of functional impairment and impact on daily living activities

Both serving personnel and veterans may claim under AFCS. Conditions that pre-existed service may still qualify if military duties demonstrably aggravated the underlying pathology. For instance, a veteran with mild pre-existing NAFLD whose condition progressed to non-alcoholic steatohepatitis (NASH) due to service-related factors may establish eligibility.

The Ministry of Defence (MOD) assesses each claim individually, considering occupational factors, deployment history, and medical records. There is no automatic entitlement; each case requires substantiation through medical evidence and service documentation. Consulting with organisations such as Veterans UK (www.gov.uk/veterans-uk) or military charities like the Royal British Legion or SSAFA can provide guidance on eligibility assessment and the claims process.

Medical Evidence Required for Your Claim

Robust medical evidence forms the cornerstone of any successful compensation claim for service-related fatty liver disease. Claimants must compile comprehensive documentation demonstrating both the diagnosis and the service connection. The evidential burden requires objective clinical findings rather than subjective symptoms alone.

Essential diagnostic evidence includes:

• Imaging studies: Ultrasound scans showing hepatic steatosis, CT scans, or MRI demonstrating fat infiltration. Note that imaging confirms steatosis but does not reliably assess fibrosis severity

• Fibrosis risk assessment: In line with NICE guideline NG49, calculation of non-invasive fibrosis scores such as FIB-4 or the NAFLD Fibrosis Score. If these indicate indeterminate or high risk of advanced fibrosis, further assessment with the Enhanced Liver Fibrosis (ELF) test or referral for specialist evaluation and transient elastography (FibroScan) to measure liver stiffness may be required

• Blood tests: Liver function tests (LFTs) including alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), and other hepatic markers. It is important to note that LFTs may be normal in NAFLD, and diagnosis relies on a combination of clinical history, imaging, and fibrosis risk stratification

• Exclusion of other causes: Tests to rule out alternative liver diseases such as viral hepatitis (hepatitis B and C serology), autoimmune liver disease (autoantibodies), and haemochromatosis (ferritin and transferrin saturation), as per UK clinical pathways

• Histological evidence: Liver biopsy results (when performed) confirming steatosis, inflammation, or fibrosis staging

• Metabolic assessments: Documentation of associated conditions such as dyslipidaemia, insulin resistance, or diabetes mellitus

Beyond diagnostic confirmation, claimants must establish causation through service medical records documenting medications with known hepatic effects or circumstances contributing to metabolic dysfunction. Documentation of prescribed medications during service or evidence of service-related injuries limiting physical activity strengthen causation arguments.

A medical opinion from a hepatologist or gastroenterologist explicitly linking the condition to service factors significantly enhances claim viability. This expert assessment should address whether, on the balance of probabilities, military service caused or materially contributed to the hepatic pathology. GP records showing symptom progression, specialist referral letters, and ongoing treatment plans provide additional supporting evidence. Veterans should request copies of all military and civilian medical records early in the claims process, as historical documentation may take considerable time to obtain.

AFCS and War Pension Scheme Compensation Levels for Liver Conditions

The UK compensation system for service-related liver conditions uses distinct structures under the Armed Forces Compensation Scheme (AFCS) and War Pension Scheme. Understanding these frameworks helps veterans anticipate potential awards.

Armed Forces Compensation Scheme (AFCS) uses a tariff-based system assigning conditions to one of 15 tariff levels. Tariff level 1 represents the most severe injuries and tariff level 15 the least severe, each corresponding to a specific lump-sum payment amount. Official AFCS tariff tables (available at www.gov.uk) detail payment amounts, which are updated annually.

For liver conditions including fatty liver disease, the tariff level depends on:

• Functional impairment: The degree to which the condition affects daily activities, work capacity, and quality of life

• Disease severity: Whether the condition represents simple steatosis, steatohepatitis, fibrosis, or cirrhosis

• Complications: Presence of portal hypertension, hepatic encephalopathy, ascites, or variceal bleeding

• Prognosis: Likelihood of progression and potential need for liver transplantation

Simple hepatic steatosis without significant inflammation or fibrosis typically attracts higher tariff numbers (lower severity), whilst progressive conditions such as NASH with advanced fibrosis or cirrhosis receive lower tariff numbers (higher severity) reflecting greater disability. The assessment considers objective medical findings including imaging, biopsy results, fibrosis scores, and biochemical markers.

For qualifying AFCS awards (typically tariff levels 1–11), veterans may also receive a Guaranteed Income Payment (GIP), an ongoing tax-free payment based on the tariff level, age at injury, and degree of functional limitation. GIP provides long-term financial support in addition to the lump sum.

Under the War Pension Scheme, assessments use a percentage-based disablement system, with awards ranging from 20% to 100%. These percentages determine ongoing pension payments. Disablement below 20% typically results in a one-off gratuity rather than a pension. Medical assessments evaluate functional capacity, considering factors such as fatigue severity, ability to maintain employment, and restrictions on physical activities.

Veterans should understand that awards are not necessarily static. Conditions may be reassessed if disease progression occurs or if new evidence emerges. Worsening from simple steatosis to cirrhosis, for example, warrants claim revision. Decisions can be reviewed and may increase or decrease depending on medical evidence and scheme policy.

How to Apply for AFCS or War Pension Scheme Compensation

UK veterans seeking compensation for service-related fatty liver disease should initiate claims through Veterans UK, the organisation administering the Armed Forces Compensation Scheme and War Pension Scheme. The application process requires careful preparation and thorough documentation to maximise the likelihood of a successful outcome.

Step-by-step application process:

1. Determine the appropriate scheme: Establish whether your service dates qualify you for AFCS (injury or illness caused by service on or after 6 April 2005) or the War Pension Scheme (earlier service). Different application forms and processes apply. Note that AFCS claims must generally be made within 7 years of the date of injury, diagnosis, or when you first knew the condition was caused by service. The War Pension Scheme has no time limit, though earlier claims are recommended.

2. Gather medical evidence: Compile all diagnostic reports, imaging studies, fibrosis risk scores (FIB-4, NAFLD Fibrosis Score, ELF test results), blood test results, specialist letters, and GP records documenting your fatty liver disease. Obtain service medical records through a Subject Access Request to the MOD if not already in your possession.

3. Complete the application form: Access the relevant online claim form via www.gov.uk/veterans-uk (search 'Claim compensation for injury or illness' for AFCS or 'Claim under the War Pension Scheme' for WPS) or request a paper copy. Form completion requires detailed information about your service history, the condition, and how service caused or contributed to it.

4. Obtain supporting statements: Written accounts from service colleagues who witnessed relevant circumstances can strengthen your claim. Medical opinions from treating clinicians explicitly linking the condition to service factors on the balance of probabilities prove particularly valuable.

5. Submit your claim: Send completed forms and supporting evidence to Veterans UK via the online portal or by post. Retain copies of all submitted materials for your records.

Processing times vary, typically ranging from several months to over a year depending on case complexity. Veterans UK may request additional medical examinations or evidence during assessment.

If your initial claim is unsuccessful, you have the right to request mandatory reconsideration within strict time limits (usually one month from the decision date). If reconsideration does not resolve the matter, you may appeal to the First-tier Tribunal (War Pensions and Armed Forces Compensation Chamber). Time limits for tribunal appeals also apply, so prompt action is essential. Details are available at www.gov.uk/appeal-war-pension.

Support organisations including the Royal British Legion (www.britishlegion.org.uk), SSAFA (www.ssafa.org.uk), and Combat Stress offer free advice and claims assistance. These charities employ specialist caseworkers experienced in navigating the compensation system and can significantly improve application quality.

When to seek urgent medical help: Contact 999 or attend A&E immediately if you experience jaundice with confusion, significant bleeding (vomiting blood or black stools), or severe abdominal swelling. Use NHS 111 for urgent advice if you develop new jaundice, persistent abdominal pain, or other concerning symptoms. These may indicate disease progression requiring urgent assessment. If you suspect an adverse reaction to any medication that may have affected your liver, report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Frequently Asked Questions